The detection of clonality in eosinophilia, such as STAT5B mutations or tyrosine kinase fusion genes, could enable the use of targeted therapies, leading to an improvement in the quality of life and survival of patients. The gene discussed is STAT5B; the disease is Increased total eosinophil count.